NCT03864042 2024-09-27Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid TumorsPfizerPhase 1 Completed56 enrolled 158 charts
NCT02688088 2022-10-18A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyEli Lilly and CompanyPhase 1 Completed48 enrolled 30 charts